Contacts
Site map
Search:
Home
Our group
Our therapeutic areas
Our Social Responsibility
R&D
Editorial
Christian Bechon
News
Thallion and LFB complete patient enrollment of Phase II Shigatec trial
09/01/2012
LFB Announces U.S. Patent on Monoclonal Antibodies with Enhanced Activity
08/07/2011
The Prix Galien was awarded to LFB in the "Medicine for the Treatment of Rare Diseases" category
25/05/2011
Thallion announces first patient enrolled in high dose cohort of phase II Shigatec trial
30/05/2011
Latest news
